Yan FF, Jiang Q, Ru B, Fei XJ, Ruan J, Zhang XC. Metastatic urothelial carcinoma harboring ERBB2/3 mutations dramatically respond to chemotherapy plus anti-PD-1 antibody: A case report. World J Clin Cases 2022; 10(8): 2497-2503 [PMID: 35434068 DOI: 10.12998/wjcc.v10.i8.2497]
Please LOGIN to submit a new comment.